nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—Prednisone—prostate cancer	0.307	1	CrCtD
Mometasone—NR3C1—prostate cancer	0.168	1	CbGaD
Mometasone—CYP2C8—Nilutamide—prostate cancer	0.0422	0.227	CbGbCtD
Mometasone—Testolactone—Estrone—prostate cancer	0.037	0.161	CrCrCtD
Mometasone—NR3C1—Prednisone—prostate cancer	0.0363	0.195	CbGbCtD
Mometasone—CYP2C8—Abiraterone—prostate cancer	0.0349	0.188	CbGbCtD
Mometasone—CYP2C8—Cabazitaxel—prostate cancer	0.0258	0.139	CbGbCtD
Mometasone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0225	0.121	CbGbCtD
Mometasone—CYP2C8—Estradiol—prostate cancer	0.0145	0.0781	CbGbCtD
Mometasone—Prednicarbate—Prednisone—prostate cancer	0.00962	0.042	CrCrCtD
Mometasone—Testolactone—Prednisone—prostate cancer	0.00962	0.042	CrCrCtD
Mometasone—CYP2C8—Etoposide—prostate cancer	0.00947	0.051	CbGbCtD
Mometasone—Fluocortolone—Prednisone—prostate cancer	0.00934	0.0408	CrCrCtD
Mometasone—Alclometasone—Prednisone—prostate cancer	0.00908	0.0396	CrCrCtD
Mometasone—Budesonide—Prednisone—prostate cancer	0.00884	0.0386	CrCrCtD
Mometasone—Amcinonide—Prednisone—prostate cancer	0.00884	0.0386	CrCrCtD
Mometasone—Clobetasol propionate—Prednisone—prostate cancer	0.00861	0.0376	CrCrCtD
Mometasone—Flunisolide—Prednisone—prostate cancer	0.00861	0.0376	CrCrCtD
Mometasone—Diflorasone—Prednisone—prostate cancer	0.00861	0.0376	CrCrCtD
Mometasone—Fludrocortisone—Prednisone—prostate cancer	0.00861	0.0376	CrCrCtD
Mometasone—Desonide—Prednisone—prostate cancer	0.00861	0.0376	CrCrCtD
Mometasone—Paramethasone—Prednisone—prostate cancer	0.00839	0.0366	CrCrCtD
Mometasone—Desoximetasone—Prednisone—prostate cancer	0.00819	0.0357	CrCrCtD
Mometasone—Fluorometholone—Prednisone—prostate cancer	0.008	0.0349	CrCrCtD
Mometasone—Triamcinolone—Prednisone—prostate cancer	0.008	0.0349	CrCrCtD
Mometasone—Fluprednidene Acetate—Prednisone—prostate cancer	0.008	0.0349	CrCrCtD
Mometasone—Loteprednol—Prednisone—prostate cancer	0.008	0.0349	CrCrCtD
Mometasone—Betamethasone—Prednisone—prostate cancer	0.00781	0.0341	CrCrCtD
Mometasone—Dexamethasone—Prednisone—prostate cancer	0.00781	0.0341	CrCrCtD
Mometasone—Rimexolone—Prednisone—prostate cancer	0.00781	0.0341	CrCrCtD
Mometasone—Methylprednisolone—Prednisone—prostate cancer	0.00747	0.0326	CrCrCtD
Mometasone—Prednisolone—Prednisone—prostate cancer	0.00732	0.0319	CrCrCtD
Mometasone—Hydrocortisone—Prednisone—prostate cancer	0.00702	0.0306	CrCrCtD
Mometasone—Amcinonide—ANXA1—prostate cancer	0.000203	0.0717	CrCbGaD
Mometasone—NR3C1—urine—prostate cancer	0.000158	0.301	CbGeAlD
Mometasone—Hydrocortisone—ANXA1—prostate cancer	8.56e-05	0.0302	CrCbGaD
Mometasone—Testolactone—CYP19A1—prostate cancer	8.17e-05	0.0288	CrCbGaD
Mometasone—Dexamethasone—CYP3A43—prostate cancer	8.07e-05	0.0285	CrCbGaD
Mometasone—Difluprednate—NR3C1—prostate cancer	6.82e-05	0.0241	CrCbGaD
Mometasone—Clocortolone—NR3C1—prostate cancer	6.62e-05	0.0234	CrCbGaD
Mometasone—Prednicarbate—NR3C1—prostate cancer	6.62e-05	0.0234	CrCbGaD
Mometasone—Dexamethasone—ANXA1—prostate cancer	6.38e-05	0.0225	CrCbGaD
Mometasone—Diflorasone—NR3C1—prostate cancer	6.26e-05	0.0221	CrCbGaD
Mometasone—Desonide—NR3C1—prostate cancer	6.26e-05	0.0221	CrCbGaD
Mometasone—Desoximetasone—NR3C1—prostate cancer	6.11e-05	0.0216	CrCbGaD
Mometasone—Loteprednol—NR3C1—prostate cancer	6.03e-05	0.0213	CrCbGaD
Mometasone—Fludrocortisone—AR—prostate cancer	5.95e-05	0.021	CrCbGaD
Mometasone—Chest pain—Mitoxantrone—prostate cancer	5.94e-05	0.000818	CcSEcCtD
Mometasone—Arthralgia—Mitoxantrone—prostate cancer	5.94e-05	0.000818	CcSEcCtD
Mometasone—Rash—Ethinyl Estradiol—prostate cancer	5.9e-05	0.000814	CcSEcCtD
Mometasone—Dermatitis—Ethinyl Estradiol—prostate cancer	5.9e-05	0.000813	CcSEcCtD
Mometasone—Headache—Ethinyl Estradiol—prostate cancer	5.87e-05	0.000808	CcSEcCtD
Mometasone—Epistaxis—Docetaxel—prostate cancer	5.82e-05	0.000802	CcSEcCtD
Mometasone—Urinary tract infection—Capecitabine—prostate cancer	5.81e-05	0.0008	CcSEcCtD
Mometasone—Conjunctivitis—Capecitabine—prostate cancer	5.81e-05	0.0008	CcSEcCtD
Mometasone—Beclomethasone—CYP3A5—prostate cancer	5.71e-05	0.0202	CrCbGaD
Mometasone—Anaphylactic shock—Mitoxantrone—prostate cancer	5.69e-05	0.000785	CcSEcCtD
Mometasone—NR3C1—prostate gland—prostate cancer	5.68e-05	0.108	CbGeAlD
Mometasone—Infection—Mitoxantrone—prostate cancer	5.66e-05	0.000779	CcSEcCtD
Mometasone—Epistaxis—Capecitabine—prostate cancer	5.63e-05	0.000777	CcSEcCtD
Mometasone—Back pain—Etoposide—prostate cancer	5.61e-05	0.000773	CcSEcCtD
Mometasone—Fluoxymesterone—SHBG—prostate cancer	5.6e-05	0.0198	CrCbGaD
Mometasone—Musculoskeletal discomfort—Estradiol—prostate cancer	5.57e-05	0.000767	CcSEcCtD
Mometasone—Nausea—Ethinyl Estradiol—prostate cancer	5.56e-05	0.000767	CcSEcCtD
Mometasone—Rhinitis—Docetaxel—prostate cancer	5.55e-05	0.000765	CcSEcCtD
Mometasone—Asthenia—Goserelin—prostate cancer	5.53e-05	0.000762	CcSEcCtD
Mometasone—Pharyngitis—Docetaxel—prostate cancer	5.5e-05	0.000758	CcSEcCtD
Mometasone—Paraesthesia—Estradiol—prostate cancer	5.49e-05	0.000756	CcSEcCtD
Mometasone—Asthenia—Conjugated Estrogens—prostate cancer	5.48e-05	0.000755	CcSEcCtD
Mometasone—Pruritus—Goserelin—prostate cancer	5.45e-05	0.000751	CcSEcCtD
Mometasone—Dyspnoea—Estradiol—prostate cancer	5.45e-05	0.000751	CcSEcCtD
Mometasone—Anorexia—Mitoxantrone—prostate cancer	5.43e-05	0.000748	CcSEcCtD
Mometasone—Pruritus—Conjugated Estrogens—prostate cancer	5.4e-05	0.000744	CcSEcCtD
Mometasone—Dyspepsia—Estradiol—prostate cancer	5.38e-05	0.000741	CcSEcCtD
Mometasone—Rhinitis—Capecitabine—prostate cancer	5.38e-05	0.000741	CcSEcCtD
Mometasone—Pharyngitis—Capecitabine—prostate cancer	5.32e-05	0.000733	CcSEcCtD
Mometasone—Decreased appetite—Estradiol—prostate cancer	5.31e-05	0.000732	CcSEcCtD
Mometasone—Diarrhoea—Goserelin—prostate cancer	5.27e-05	0.000727	CcSEcCtD
Mometasone—Fatigue—Estradiol—prostate cancer	5.27e-05	0.000726	CcSEcCtD
Mometasone—Flumethasone Pivalate—NR3C1—prostate cancer	5.26e-05	0.0186	CrCbGaD
Mometasone—Pain—Estradiol—prostate cancer	5.22e-05	0.00072	CcSEcCtD
Mometasone—Diarrhoea—Conjugated Estrogens—prostate cancer	5.22e-05	0.00072	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	5.19e-05	0.000715	CcSEcCtD
Mometasone—Halobetasol Propionate—NR3C1—prostate cancer	5.17e-05	0.0183	CrCbGaD
Mometasone—Paraesthesia—Mitoxantrone—prostate cancer	5.11e-05	0.000704	CcSEcCtD
Mometasone—Dyspnoea—Mitoxantrone—prostate cancer	5.08e-05	0.000699	CcSEcCtD
Mometasone—Cough—Etoposide—prostate cancer	5.06e-05	0.000698	CcSEcCtD
Mometasone—Dyspepsia—Mitoxantrone—prostate cancer	5.01e-05	0.000691	CcSEcCtD
Mometasone—Immune system disorder—Docetaxel—prostate cancer	5e-05	0.000689	CcSEcCtD
Mometasone—Gastrointestinal pain—Estradiol—prostate cancer	5e-05	0.000688	CcSEcCtD
Mometasone—Mediastinal disorder—Docetaxel—prostate cancer	4.99e-05	0.000688	CcSEcCtD
Mometasone—Decreased appetite—Mitoxantrone—prostate cancer	4.95e-05	0.000682	CcSEcCtD
Mometasone—Chest pain—Etoposide—prostate cancer	4.94e-05	0.000681	CcSEcCtD
Mometasone—Fluoxymesterone—AR—prostate cancer	4.91e-05	0.0173	CrCbGaD
Mometasone—Fatigue—Mitoxantrone—prostate cancer	4.91e-05	0.000676	CcSEcCtD
Mometasone—Vomiting—Goserelin—prostate cancer	4.9e-05	0.000675	CcSEcCtD
Mometasone—Pain—Mitoxantrone—prostate cancer	4.87e-05	0.000671	CcSEcCtD
Mometasone—Rash—Goserelin—prostate cancer	4.86e-05	0.00067	CcSEcCtD
Mometasone—Dermatitis—Goserelin—prostate cancer	4.85e-05	0.000669	CcSEcCtD
Mometasone—Vomiting—Conjugated Estrogens—prostate cancer	4.85e-05	0.000669	CcSEcCtD
Mometasone—Immune system disorder—Capecitabine—prostate cancer	4.84e-05	0.000668	CcSEcCtD
Mometasone—Mediastinal disorder—Capecitabine—prostate cancer	4.83e-05	0.000666	CcSEcCtD
Mometasone—Abdominal pain—Estradiol—prostate cancer	4.83e-05	0.000666	CcSEcCtD
Mometasone—Body temperature increased—Estradiol—prostate cancer	4.83e-05	0.000666	CcSEcCtD
Mometasone—Nasopharyngitis—Epirubicin—prostate cancer	4.83e-05	0.000666	CcSEcCtD
Mometasone—Headache—Goserelin—prostate cancer	4.83e-05	0.000665	CcSEcCtD
Mometasone—Rash—Conjugated Estrogens—prostate cancer	4.81e-05	0.000663	CcSEcCtD
Mometasone—Dermatitis—Conjugated Estrogens—prostate cancer	4.81e-05	0.000663	CcSEcCtD
Mometasone—Budesonide—NR3C1—prostate cancer	4.81e-05	0.017	CrCbGaD
Mometasone—Amcinonide—NR3C1—prostate cancer	4.81e-05	0.017	CrCbGaD
Mometasone—NR3C1—seminal vesicle—prostate cancer	4.8e-05	0.0915	CbGeAlD
Mometasone—Headache—Conjugated Estrogens—prostate cancer	4.78e-05	0.000659	CcSEcCtD
Mometasone—Anaphylactic shock—Etoposide—prostate cancer	4.74e-05	0.000653	CcSEcCtD
Mometasone—Fluticasone furoate—NR3C1—prostate cancer	4.72e-05	0.0166	CrCbGaD
Mometasone—Infection—Etoposide—prostate cancer	4.7e-05	0.000648	CcSEcCtD
Mometasone—Influenza—Epirubicin—prostate cancer	4.67e-05	0.000643	CcSEcCtD
Mometasone—Asthma—Epirubicin—prostate cancer	4.67e-05	0.000643	CcSEcCtD
Mometasone—Back pain—Docetaxel—prostate cancer	4.66e-05	0.000643	CcSEcCtD
Mometasone—Gastrointestinal pain—Mitoxantrone—prostate cancer	4.66e-05	0.000642	CcSEcCtD
Mometasone—Nausea—Goserelin—prostate cancer	4.58e-05	0.000631	CcSEcCtD
Mometasone—Nausea—Conjugated Estrogens—prostate cancer	4.53e-05	0.000625	CcSEcCtD
Mometasone—Rimexolone—NR3C1—prostate cancer	4.52e-05	0.016	CrCbGaD
Mometasone—Back pain—Capecitabine—prostate cancer	4.52e-05	0.000622	CcSEcCtD
Mometasone—Anorexia—Etoposide—prostate cancer	4.51e-05	0.000622	CcSEcCtD
Mometasone—Abdominal pain—Mitoxantrone—prostate cancer	4.5e-05	0.00062	CcSEcCtD
Mometasone—Body temperature increased—Mitoxantrone—prostate cancer	4.5e-05	0.00062	CcSEcCtD
Mometasone—Bronchitis—Epirubicin—prostate cancer	4.49e-05	0.000619	CcSEcCtD
Mometasone—Nasopharyngitis—Doxorubicin—prostate cancer	4.47e-05	0.000616	CcSEcCtD
Mometasone—Asthenia—Estradiol—prostate cancer	4.38e-05	0.000604	CcSEcCtD
Mometasone—Upper respiratory tract infection—Epirubicin—prostate cancer	4.34e-05	0.000598	CcSEcCtD
Mometasone—Pruritus—Estradiol—prostate cancer	4.32e-05	0.000596	CcSEcCtD
Mometasone—CYP2C8—renal system—prostate cancer	4.32e-05	0.0823	CbGeAlD
Mometasone—Influenza—Doxorubicin—prostate cancer	4.32e-05	0.000595	CcSEcCtD
Mometasone—Asthma—Doxorubicin—prostate cancer	4.32e-05	0.000595	CcSEcCtD
Mometasone—Immune system disorder—Prednisone—prostate cancer	4.31e-05	0.000595	CcSEcCtD
Mometasone—Beclomethasone—NR3C1—prostate cancer	4.26e-05	0.015	CrCbGaD
Mometasone—Fluocinonide—NR3C1—prostate cancer	4.26e-05	0.015	CrCbGaD
Mometasone—Paraesthesia—Etoposide—prostate cancer	4.25e-05	0.000586	CcSEcCtD
Mometasone—Dyspnoea—Etoposide—prostate cancer	4.22e-05	0.000582	CcSEcCtD
Mometasone—Cough—Docetaxel—prostate cancer	4.21e-05	0.00058	CcSEcCtD
Mometasone—Diarrhoea—Estradiol—prostate cancer	4.18e-05	0.000576	CcSEcCtD
Mometasone—NR3C1—epithelium—prostate cancer	4.17e-05	0.0795	CbGeAlD
Mometasone—Bronchitis—Doxorubicin—prostate cancer	4.15e-05	0.000572	CcSEcCtD
Mometasone—Alclometasone—NR3C1—prostate cancer	4.14e-05	0.0146	CrCbGaD
Mometasone—Fluocinolone Acetonide—NR3C1—prostate cancer	4.14e-05	0.0146	CrCbGaD
Mometasone—Decreased appetite—Etoposide—prostate cancer	4.12e-05	0.000567	CcSEcCtD
Mometasone—Myalgia—Docetaxel—prostate cancer	4.11e-05	0.000566	CcSEcCtD
Mometasone—Arthralgia—Docetaxel—prostate cancer	4.11e-05	0.000566	CcSEcCtD
Mometasone—Chest pain—Docetaxel—prostate cancer	4.11e-05	0.000566	CcSEcCtD
Mometasone—Asthenia—Mitoxantrone—prostate cancer	4.08e-05	0.000563	CcSEcCtD
Mometasone—Fatigue—Etoposide—prostate cancer	4.08e-05	0.000563	CcSEcCtD
Mometasone—Cough—Capecitabine—prostate cancer	4.07e-05	0.000561	CcSEcCtD
Mometasone—Pain—Etoposide—prostate cancer	4.05e-05	0.000558	CcSEcCtD
Mometasone—Conjunctivitis—Epirubicin—prostate cancer	4.05e-05	0.000557	CcSEcCtD
Mometasone—Urinary tract infection—Epirubicin—prostate cancer	4.05e-05	0.000557	CcSEcCtD
Mometasone—Flunisolide—NR3C1—prostate cancer	4.03e-05	0.0142	CrCbGaD
Mometasone—Clobetasol propionate—NR3C1—prostate cancer	4.03e-05	0.0142	CrCbGaD
Mometasone—Fludrocortisone—NR3C1—prostate cancer	4.03e-05	0.0142	CrCbGaD
Mometasone—Dry mouth—Docetaxel—prostate cancer	4.01e-05	0.000553	CcSEcCtD
Mometasone—Upper respiratory tract infection—Doxorubicin—prostate cancer	4.01e-05	0.000553	CcSEcCtD
Mometasone—Paramethasone—NR3C1—prostate cancer	3.98e-05	0.0141	CrCbGaD
Mometasone—Chest pain—Capecitabine—prostate cancer	3.97e-05	0.000548	CcSEcCtD
Mometasone—Arthralgia—Capecitabine—prostate cancer	3.97e-05	0.000548	CcSEcCtD
Mometasone—Myalgia—Capecitabine—prostate cancer	3.97e-05	0.000548	CcSEcCtD
Mometasone—Anaphylactic shock—Docetaxel—prostate cancer	3.94e-05	0.000542	CcSEcCtD
Mometasone—Epistaxis—Epirubicin—prostate cancer	3.93e-05	0.000541	CcSEcCtD
Mometasone—Infection—Docetaxel—prostate cancer	3.91e-05	0.000539	CcSEcCtD
Mometasone—Sinusitis—Epirubicin—prostate cancer	3.9e-05	0.000538	CcSEcCtD
Mometasone—Diarrhoea—Mitoxantrone—prostate cancer	3.9e-05	0.000537	CcSEcCtD
Mometasone—Fluorometholone—NR3C1—prostate cancer	3.89e-05	0.0137	CrCbGaD
Mometasone—Dry mouth—Capecitabine—prostate cancer	3.89e-05	0.000536	CcSEcCtD
Mometasone—Vomiting—Estradiol—prostate cancer	3.88e-05	0.000535	CcSEcCtD
Mometasone—Gastrointestinal pain—Etoposide—prostate cancer	3.87e-05	0.000534	CcSEcCtD
Mometasone—NR3C1—renal system—prostate cancer	3.87e-05	0.0737	CbGeAlD
Mometasone—Rash—Estradiol—prostate cancer	3.85e-05	0.000531	CcSEcCtD
Mometasone—Dermatitis—Estradiol—prostate cancer	3.85e-05	0.00053	CcSEcCtD
Mometasone—Headache—Estradiol—prostate cancer	3.83e-05	0.000527	CcSEcCtD
Mometasone—NR3C1—urethra—prostate cancer	3.8e-05	0.0724	CbGeAlD
Mometasone—Angioedema—Prednisone—prostate cancer	3.8e-05	0.000524	CcSEcCtD
Mometasone—Fluticasone Propionate—CYP3A5—prostate cancer	3.79e-05	0.0134	CrCbGaD
Mometasone—Fluoxymesterone—ESR1—prostate cancer	3.79e-05	0.0134	CrCbGaD
Mometasone—Infection—Capecitabine—prostate cancer	3.79e-05	0.000522	CcSEcCtD
Mometasone—Methylprednisolone—NR3C1—prostate cancer	3.76e-05	0.0133	CrCbGaD
Mometasone—Anorexia—Docetaxel—prostate cancer	3.75e-05	0.000517	CcSEcCtD
Mometasone—Rhinitis—Epirubicin—prostate cancer	3.75e-05	0.000516	CcSEcCtD
Mometasone—Body temperature increased—Etoposide—prostate cancer	3.74e-05	0.000516	CcSEcCtD
Mometasone—Abdominal pain—Etoposide—prostate cancer	3.74e-05	0.000516	CcSEcCtD
Mometasone—Conjunctivitis—Doxorubicin—prostate cancer	3.74e-05	0.000516	CcSEcCtD
Mometasone—Urinary tract infection—Doxorubicin—prostate cancer	3.74e-05	0.000516	CcSEcCtD
Mometasone—Pharyngitis—Epirubicin—prostate cancer	3.71e-05	0.000511	CcSEcCtD
Mometasone—Dexamethasone—CYP17A1—prostate cancer	3.66e-05	0.0129	CrCbGaD
Mometasone—Clobetasol propionate—CYP1A1—prostate cancer	3.66e-05	0.0129	CrCbGaD
Mometasone—Epistaxis—Doxorubicin—prostate cancer	3.63e-05	0.000501	CcSEcCtD
Mometasone—Anorexia—Capecitabine—prostate cancer	3.63e-05	0.0005	CcSEcCtD
Mometasone—Nausea—Estradiol—prostate cancer	3.63e-05	0.0005	CcSEcCtD
Mometasone—Vomiting—Mitoxantrone—prostate cancer	3.62e-05	0.000499	CcSEcCtD
Mometasone—Sinusitis—Doxorubicin—prostate cancer	3.61e-05	0.000498	CcSEcCtD
Mometasone—Rash—Mitoxantrone—prostate cancer	3.59e-05	0.000495	CcSEcCtD
Mometasone—Dermatitis—Mitoxantrone—prostate cancer	3.59e-05	0.000494	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.59e-05	0.000494	CcSEcCtD
Mometasone—Headache—Mitoxantrone—prostate cancer	3.57e-05	0.000491	CcSEcCtD
Mometasone—Arthralgia—Prednisone—prostate cancer	3.54e-05	0.000488	CcSEcCtD
Mometasone—Myalgia—Prednisone—prostate cancer	3.54e-05	0.000488	CcSEcCtD
Mometasone—Paraesthesia—Docetaxel—prostate cancer	3.53e-05	0.000487	CcSEcCtD
Mometasone—Dyspnoea—Docetaxel—prostate cancer	3.51e-05	0.000483	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.47e-05	0.000478	CcSEcCtD
Mometasone—Rhinitis—Doxorubicin—prostate cancer	3.47e-05	0.000478	CcSEcCtD
Mometasone—Dyspepsia—Docetaxel—prostate cancer	3.46e-05	0.000477	CcSEcCtD
Mometasone—Prednisolone—CYP2A6—prostate cancer	3.44e-05	0.0121	CrCbGaD
Mometasone—Pharyngitis—Doxorubicin—prostate cancer	3.43e-05	0.000473	CcSEcCtD
Mometasone—Paraesthesia—Capecitabine—prostate cancer	3.42e-05	0.000471	CcSEcCtD
Mometasone—Decreased appetite—Docetaxel—prostate cancer	3.42e-05	0.000471	CcSEcCtD
Mometasone—Hydrocortisone—SHBG—prostate cancer	3.41e-05	0.012	CrCbGaD
Mometasone—Asthenia—Etoposide—prostate cancer	3.4e-05	0.000468	CcSEcCtD
Mometasone—Dyspnoea—Capecitabine—prostate cancer	3.4e-05	0.000468	CcSEcCtD
Mometasone—Anaphylactic shock—Prednisone—prostate cancer	3.39e-05	0.000468	CcSEcCtD
Mometasone—Fatigue—Docetaxel—prostate cancer	3.39e-05	0.000468	CcSEcCtD
Mometasone—Nausea—Mitoxantrone—prostate cancer	3.38e-05	0.000466	CcSEcCtD
Mometasone—Immune system disorder—Epirubicin—prostate cancer	3.37e-05	0.000465	CcSEcCtD
Mometasone—Infection—Prednisone—prostate cancer	3.37e-05	0.000465	CcSEcCtD
Mometasone—Mediastinal disorder—Epirubicin—prostate cancer	3.37e-05	0.000464	CcSEcCtD
Mometasone—Pain—Docetaxel—prostate cancer	3.37e-05	0.000464	CcSEcCtD
Mometasone—Dyspepsia—Capecitabine—prostate cancer	3.35e-05	0.000462	CcSEcCtD
Mometasone—Pruritus—Etoposide—prostate cancer	3.35e-05	0.000462	CcSEcCtD
Mometasone—Fluoxymesterone—NR3C1—prostate cancer	3.33e-05	0.0118	CrCbGaD
Mometasone—Decreased appetite—Capecitabine—prostate cancer	3.31e-05	0.000456	CcSEcCtD
Mometasone—Fatigue—Capecitabine—prostate cancer	3.28e-05	0.000453	CcSEcCtD
Mometasone—Pain—Capecitabine—prostate cancer	3.26e-05	0.000449	CcSEcCtD
Mometasone—Diarrhoea—Etoposide—prostate cancer	3.24e-05	0.000446	CcSEcCtD
Mometasone—Anorexia—Prednisone—prostate cancer	3.24e-05	0.000446	CcSEcCtD
Mometasone—Gastrointestinal pain—Docetaxel—prostate cancer	3.22e-05	0.000443	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	3.21e-05	0.000949	CbGpPWpGaD
Mometasone—Betamethasone—CYP19A1—prostate cancer	3.2e-05	0.0113	CrCbGaD
Mometasone—NR3C1—Adipogenesis—IRS1—prostate cancer	3.2e-05	0.000944	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—AKR1C3—prostate cancer	3.2e-05	0.000944	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP17A1—prostate cancer	3.19e-05	0.000942	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NFIC—prostate cancer	3.17e-05	0.000938	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	3.17e-05	0.000937	CbGpPWpGaD
Mometasone—Triamcinolone—NR3C1—prostate cancer	3.17e-05	0.0112	CrCbGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP17A1—prostate cancer	3.15e-05	0.000929	CbGpPWpGaD
Mometasone—Back pain—Epirubicin—prostate cancer	3.15e-05	0.000434	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	3.13e-05	0.000925	CbGpPWpGaD
Mometasone—Immune system disorder—Doxorubicin—prostate cancer	3.12e-05	0.00043	CcSEcCtD
Mometasone—Gastrointestinal pain—Capecitabine—prostate cancer	3.12e-05	0.000429	CcSEcCtD
Mometasone—Mediastinal disorder—Doxorubicin—prostate cancer	3.12e-05	0.000429	CcSEcCtD
Mometasone—Abdominal pain—Docetaxel—prostate cancer	3.11e-05	0.000429	CcSEcCtD
Mometasone—Body temperature increased—Docetaxel—prostate cancer	3.11e-05	0.000429	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	3.1e-05	0.000916	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Prednisone—prostate cancer	3.09e-05	0.000426	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—INS—prostate cancer	3.06e-05	0.000904	CbGpPWpGaD
Mometasone—Paraesthesia—Prednisone—prostate cancer	3.05e-05	0.00042	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	3.05e-05	0.0009	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	3.05e-05	0.0009	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	3.05e-05	0.0009	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—NCOA2—prostate cancer	3.04e-05	0.000898	CbGpPWpGaD
Mometasone—Abdominal pain—Capecitabine—prostate cancer	3.01e-05	0.000415	CcSEcCtD
Mometasone—Body temperature increased—Capecitabine—prostate cancer	3.01e-05	0.000415	CcSEcCtD
Mometasone—Vomiting—Etoposide—prostate cancer	3.01e-05	0.000415	CcSEcCtD
Mometasone—Dyspepsia—Prednisone—prostate cancer	2.99e-05	0.000412	CcSEcCtD
Mometasone—Rash—Etoposide—prostate cancer	2.99e-05	0.000411	CcSEcCtD
Mometasone—NR3C1—Gene Expression—RPN2—prostate cancer	2.99e-05	0.000882	CbGpPWpGaD
Mometasone—Dermatitis—Etoposide—prostate cancer	2.98e-05	0.000411	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	2.98e-05	0.000881	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	2.98e-05	0.00088	CbGpPWpGaD
Mometasone—Headache—Etoposide—prostate cancer	2.97e-05	0.000409	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—IGF1—prostate cancer	2.96e-05	0.000875	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	2.95e-05	0.000872	CbGpPWpGaD
Mometasone—Decreased appetite—Prednisone—prostate cancer	2.95e-05	0.000407	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	2.94e-05	0.000867	CbGpPWpGaD
Mometasone—NR3C1—bone marrow—prostate cancer	2.93e-05	0.0557	CbGeAlD
Mometasone—Fatigue—Prednisone—prostate cancer	2.93e-05	0.000403	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	2.92e-05	0.000862	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	2.91e-05	0.00086	CbGpPWpGaD
Mometasone—Back pain—Doxorubicin—prostate cancer	2.91e-05	0.000401	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	2.91e-05	0.000858	CbGpPWpGaD
Mometasone—Prednisone—NR3C1—prostate cancer	2.88e-05	0.0101	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	2.87e-05	0.000848	CbGpPWpGaD
Mometasone—Cough—Epirubicin—prostate cancer	2.84e-05	0.000391	CcSEcCtD
Mometasone—Fluticasone Propionate—NR3C1—prostate cancer	2.83e-05	0.01	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—CYP2E1—prostate cancer	2.83e-05	0.000837	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—QARS—prostate cancer	2.83e-05	0.000836	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	2.82e-05	0.000834	CbGpPWpGaD
Mometasone—Asthenia—Docetaxel—prostate cancer	2.82e-05	0.000389	CcSEcCtD
Mometasone—Nausea—Etoposide—prostate cancer	2.81e-05	0.000388	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—SERPINE1—prostate cancer	2.81e-05	0.00083	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2E1—prostate cancer	2.79e-05	0.000825	CbGpPWpGaD
Mometasone—CYP2C8—testis—prostate cancer	2.79e-05	0.0532	CbGeAlD
Mometasone—Budesonide—CYP3A4—prostate cancer	2.79e-05	0.00984	CrCbGaD
Mometasone—Pruritus—Docetaxel—prostate cancer	2.78e-05	0.000384	CcSEcCtD
Mometasone—Gastrointestinal pain—Prednisone—prostate cancer	2.78e-05	0.000382	CcSEcCtD
Mometasone—Arthralgia—Epirubicin—prostate cancer	2.77e-05	0.000382	CcSEcCtD
Mometasone—Chest pain—Epirubicin—prostate cancer	2.77e-05	0.000382	CcSEcCtD
Mometasone—Myalgia—Epirubicin—prostate cancer	2.77e-05	0.000382	CcSEcCtD
Mometasone—Asthenia—Capecitabine—prostate cancer	2.73e-05	0.000377	CcSEcCtD
Mometasone—Fluticasone furoate—CYP3A4—prostate cancer	2.73e-05	0.00965	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—CYP3A4—prostate cancer	2.73e-05	0.000807	CbGpPWpGaD
Mometasone—Hydrocortisone—CYP3A5—prostate cancer	2.71e-05	0.00958	CrCbGaD
Mometasone—Dry mouth—Epirubicin—prostate cancer	2.71e-05	0.000373	CcSEcCtD
Mometasone—Pruritus—Capecitabine—prostate cancer	2.7e-05	0.000371	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—CYP3A4—prostate cancer	2.69e-05	0.000796	CbGpPWpGaD
Mometasone—Diarrhoea—Docetaxel—prostate cancer	2.69e-05	0.000371	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—CYP1B1—prostate cancer	2.69e-05	0.000793	CbGpPWpGaD
Mometasone—Body temperature increased—Prednisone—prostate cancer	2.68e-05	0.00037	CcSEcCtD
Mometasone—Abdominal pain—Prednisone—prostate cancer	2.68e-05	0.00037	CcSEcCtD
Mometasone—Anaphylactic shock—Epirubicin—prostate cancer	2.65e-05	0.000366	CcSEcCtD
Mometasone—Prednisolone—NR3C1—prostate cancer	2.65e-05	0.00935	CrCbGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1B1—prostate cancer	2.65e-05	0.000782	CbGpPWpGaD
Mometasone—Infection—Epirubicin—prostate cancer	2.64e-05	0.000363	CcSEcCtD
Mometasone—Cough—Doxorubicin—prostate cancer	2.63e-05	0.000362	CcSEcCtD
Mometasone—Prednisone—CYP2C19—prostate cancer	2.62e-05	0.00925	CrCbGaD
Mometasone—Diarrhoea—Capecitabine—prostate cancer	2.61e-05	0.000359	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GGT1—prostate cancer	2.6e-05	0.000768	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	2.6e-05	0.000767	CbGpPWpGaD
Mometasone—Betamethasone—NR3C1—prostate cancer	2.6e-05	0.00916	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	2.59e-05	0.000765	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	2.59e-05	0.000765	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TBX5—prostate cancer	2.59e-05	0.000764	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—NCOA1—prostate cancer	2.56e-05	0.000757	CbGpPWpGaD
Mometasone—Myalgia—Doxorubicin—prostate cancer	2.56e-05	0.000353	CcSEcCtD
Mometasone—Arthralgia—Doxorubicin—prostate cancer	2.56e-05	0.000353	CcSEcCtD
Mometasone—Chest pain—Doxorubicin—prostate cancer	2.56e-05	0.000353	CcSEcCtD
Mometasone—Dexamethasone—CYP1B1—prostate cancer	2.54e-05	0.00896	CrCbGaD
Mometasone—Anorexia—Epirubicin—prostate cancer	2.53e-05	0.000349	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—CYP19A1—prostate cancer	2.53e-05	0.000746	CbGpPWpGaD
Mometasone—Dry mouth—Doxorubicin—prostate cancer	2.51e-05	0.000345	CcSEcCtD
Mometasone—NR3C1—testis—prostate cancer	2.5e-05	0.0476	CbGeAlD
Mometasone—Vomiting—Docetaxel—prostate cancer	2.5e-05	0.000345	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—CYP19A1—prostate cancer	2.49e-05	0.000735	CbGpPWpGaD
Mometasone—Rash—Docetaxel—prostate cancer	2.48e-05	0.000342	CcSEcCtD
Mometasone—Dermatitis—Docetaxel—prostate cancer	2.48e-05	0.000342	CcSEcCtD
Mometasone—Headache—Docetaxel—prostate cancer	2.47e-05	0.00034	CcSEcCtD
Mometasone—Anaphylactic shock—Doxorubicin—prostate cancer	2.46e-05	0.000338	CcSEcCtD
Mometasone—Infection—Doxorubicin—prostate cancer	2.44e-05	0.000336	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—RXRA—prostate cancer	2.44e-05	0.00072	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	2.44e-05	0.000719	CbGpPWpGaD
Mometasone—Asthenia—Prednisone—prostate cancer	2.43e-05	0.000336	CcSEcCtD
Mometasone—Vomiting—Capecitabine—prostate cancer	2.42e-05	0.000334	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.42e-05	0.000333	CcSEcCtD
Mometasone—NR3C1—Gene Expression—EIF3H—prostate cancer	2.41e-05	0.000711	CbGpPWpGaD
Mometasone—Rash—Capecitabine—prostate cancer	2.4e-05	0.000331	CcSEcCtD
Mometasone—Alclometasone—CYP3A4—prostate cancer	2.4e-05	0.00848	CrCbGaD
Mometasone—Pruritus—Prednisone—prostate cancer	2.4e-05	0.000331	CcSEcCtD
Mometasone—Dermatitis—Capecitabine—prostate cancer	2.4e-05	0.000331	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	2.4e-05	0.000708	CbGpPWpGaD
Mometasone—Headache—Capecitabine—prostate cancer	2.39e-05	0.000329	CcSEcCtD
Mometasone—Paraesthesia—Epirubicin—prostate cancer	2.38e-05	0.000328	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	2.37e-05	0.0007	CbGpPWpGaD
Mometasone—Dyspnoea—Epirubicin—prostate cancer	2.37e-05	0.000326	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—COMT—prostate cancer	2.35e-05	0.000693	CbGpPWpGaD
Mometasone—Anorexia—Doxorubicin—prostate cancer	2.34e-05	0.000323	CcSEcCtD
Mometasone—Flunisolide—CYP3A4—prostate cancer	2.34e-05	0.00825	CrCbGaD
Mometasone—Nausea—Docetaxel—prostate cancer	2.34e-05	0.000322	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTP1—prostate cancer	2.34e-05	0.00069	CbGpPWpGaD
Mometasone—Dyspepsia—Epirubicin—prostate cancer	2.34e-05	0.000322	CcSEcCtD
Mometasone—Diarrhoea—Prednisone—prostate cancer	2.32e-05	0.00032	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—COMT—prostate cancer	2.32e-05	0.000684	CbGpPWpGaD
Mometasone—Paramethasone—CYP3A4—prostate cancer	2.31e-05	0.00815	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	2.31e-05	0.000682	CbGpPWpGaD
Mometasone—Decreased appetite—Epirubicin—prostate cancer	2.31e-05	0.000318	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—GSTP1—prostate cancer	2.3e-05	0.00068	CbGpPWpGaD
Mometasone—Fatigue—Epirubicin—prostate cancer	2.29e-05	0.000315	CcSEcCtD
Mometasone—Pain—Epirubicin—prostate cancer	2.27e-05	0.000313	CcSEcCtD
Mometasone—Nausea—Capecitabine—prostate cancer	2.26e-05	0.000312	CcSEcCtD
Mometasone—Fluorometholone—CYP3A4—prostate cancer	2.25e-05	0.00795	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	2.25e-05	0.000665	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.24e-05	0.000308	CcSEcCtD
Mometasone—Paraesthesia—Doxorubicin—prostate cancer	2.21e-05	0.000304	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	2.2e-05	0.00065	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	2.2e-05	0.00065	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CTNNB1—prostate cancer	2.2e-05	0.000649	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	2.2e-05	0.000648	CbGpPWpGaD
Mometasone—Dyspnoea—Doxorubicin—prostate cancer	2.19e-05	0.000302	CcSEcCtD
Mometasone—Methylprednisolone—CYP3A4—prostate cancer	2.18e-05	0.00769	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	2.18e-05	0.000642	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Epirubicin—prostate cancer	2.17e-05	0.000299	CcSEcCtD
Mometasone—Dyspepsia—Doxorubicin—prostate cancer	2.16e-05	0.000298	CcSEcCtD
Mometasone—Vomiting—Prednisone—prostate cancer	2.16e-05	0.000297	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTM1—prostate cancer	2.15e-05	0.000634	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CDKN1A—prostate cancer	2.15e-05	0.000634	CbGpPWpGaD
Mometasone—Rash—Prednisone—prostate cancer	2.14e-05	0.000295	CcSEcCtD
Mometasone—Dermatitis—Prednisone—prostate cancer	2.14e-05	0.000295	CcSEcCtD
Mometasone—Decreased appetite—Doxorubicin—prostate cancer	2.13e-05	0.000294	CcSEcCtD
Mometasone—Headache—Prednisone—prostate cancer	2.13e-05	0.000293	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM1—prostate cancer	2.12e-05	0.000625	CbGpPWpGaD
Mometasone—Fatigue—Doxorubicin—prostate cancer	2.12e-05	0.000292	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	2.11e-05	0.000624	CbGpPWpGaD
Mometasone—Pain—Doxorubicin—prostate cancer	2.1e-05	0.000289	CcSEcCtD
Mometasone—Abdominal pain—Epirubicin—prostate cancer	2.1e-05	0.000289	CcSEcCtD
Mometasone—Body temperature increased—Epirubicin—prostate cancer	2.1e-05	0.000289	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	2.06e-05	0.000608	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	2.06e-05	0.000608	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1A1—prostate cancer	2.04e-05	0.000601	CbGpPWpGaD
Mometasone—Hydrocortisone—NR3C1—prostate cancer	2.03e-05	0.00715	CrCbGaD
Mometasone—Dexamethasone—CYP3A5—prostate cancer	2.02e-05	0.00714	CrCbGaD
Mometasone—Nausea—Prednisone—prostate cancer	2.02e-05	0.000278	CcSEcCtD
Mometasone—CYP2C8—Metabolism—HAO1—prostate cancer	2.01e-05	0.000593	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Doxorubicin—prostate cancer	2.01e-05	0.000277	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1A1—prostate cancer	2.01e-05	0.000593	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.97e-05	0.000582	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TET2—prostate cancer	1.96e-05	0.000579	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MBD2—prostate cancer	1.96e-05	0.000579	CbGpPWpGaD
Mometasone—Dexamethasone—CYP2A6—prostate cancer	1.96e-05	0.00691	CrCbGaD
Mometasone—Abdominal pain—Doxorubicin—prostate cancer	1.94e-05	0.000268	CcSEcCtD
Mometasone—Body temperature increased—Doxorubicin—prostate cancer	1.94e-05	0.000268	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.93e-05	0.000571	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—RPL12—prostate cancer	1.92e-05	0.000568	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—STAT3—prostate cancer	1.92e-05	0.000566	CbGpPWpGaD
Mometasone—Asthenia—Epirubicin—prostate cancer	1.9e-05	0.000262	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.9e-05	0.000561	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.9e-05	0.00056	CbGpPWpGaD
Mometasone—Pruritus—Epirubicin—prostate cancer	1.88e-05	0.000259	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	1.87e-05	0.000553	CbGpPWpGaD
Mometasone—Dexamethasone—CYP19A1—prostate cancer	1.86e-05	0.00658	CrCbGaD
Mometasone—Triamcinolone—CYP3A4—prostate cancer	1.84e-05	0.00648	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.82e-05	0.000537	CbGpPWpGaD
Mometasone—Diarrhoea—Epirubicin—prostate cancer	1.82e-05	0.00025	CcSEcCtD
Mometasone—NR3C1—lymph node—prostate cancer	1.81e-05	0.0345	CbGeAlD
Mometasone—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.81e-05	0.000533	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.8e-05	0.000532	CbGpPWpGaD
Mometasone—Triamcinolone—PTGS2—prostate cancer	1.8e-05	0.00635	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	1.8e-05	0.00053	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.78e-05	0.000527	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.78e-05	0.000524	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EIF3A—prostate cancer	1.77e-05	0.000522	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.77e-05	0.000521	CbGpPWpGaD
Mometasone—Asthenia—Doxorubicin—prostate cancer	1.76e-05	0.000243	CcSEcCtD
Mometasone—Pruritus—Doxorubicin—prostate cancer	1.74e-05	0.000239	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	1.73e-05	0.00051	CbGpPWpGaD
Mometasone—Vomiting—Epirubicin—prostate cancer	1.69e-05	0.000233	CcSEcCtD
Mometasone—Diarrhoea—Doxorubicin—prostate cancer	1.68e-05	0.000232	CcSEcCtD
Mometasone—Rash—Epirubicin—prostate cancer	1.67e-05	0.000231	CcSEcCtD
Mometasone—Dermatitis—Epirubicin—prostate cancer	1.67e-05	0.00023	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.67e-05	0.000494	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	1.67e-05	0.000493	CbGpPWpGaD
Mometasone—Prednisone—CYP3A4—prostate cancer	1.67e-05	0.00588	CrCbGaD
Mometasone—Headache—Epirubicin—prostate cancer	1.66e-05	0.000229	CcSEcCtD
Mometasone—Fluticasone Propionate—CYP3A4—prostate cancer	1.64e-05	0.0058	CrCbGaD
Mometasone—CYP2C8—Metabolism—CSAD—prostate cancer	1.64e-05	0.000484	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PSAT1—prostate cancer	1.64e-05	0.000484	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GRHL1—prostate cancer	1.64e-05	0.000484	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CBR1—prostate cancer	1.64e-05	0.000484	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADI1—prostate cancer	1.64e-05	0.000484	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TST—prostate cancer	1.64e-05	0.000484	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.64e-05	0.000483	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	1.6e-05	0.000473	CbGpPWpGaD
Mometasone—Nausea—Epirubicin—prostate cancer	1.58e-05	0.000217	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	1.57e-05	0.000463	CbGpPWpGaD
Mometasone—Vomiting—Doxorubicin—prostate cancer	1.56e-05	0.000215	CcSEcCtD
Mometasone—Rash—Doxorubicin—prostate cancer	1.55e-05	0.000213	CcSEcCtD
Mometasone—Dermatitis—Doxorubicin—prostate cancer	1.55e-05	0.000213	CcSEcCtD
Mometasone—Headache—Doxorubicin—prostate cancer	1.54e-05	0.000212	CcSEcCtD
Mometasone—Prednisolone—CYP3A4—prostate cancer	1.54e-05	0.00542	CrCbGaD
Mometasone—CYP2C8—Metabolism—GRHPR—prostate cancer	1.52e-05	0.00045	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CKMT2—prostate cancer	1.52e-05	0.00045	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UGT2B15—prostate cancer	1.52e-05	0.00045	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UGT2B17—prostate cancer	1.52e-05	0.00045	CbGpPWpGaD
Mometasone—Dexamethasone—NR3C1—prostate cancer	1.51e-05	0.00533	CrCbGaD
Mometasone—Betamethasone—CYP3A4—prostate cancer	1.51e-05	0.00531	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.49e-05	0.000439	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—DNMT3B—prostate cancer	1.49e-05	0.000439	CbGpPWpGaD
Mometasone—Betamethasone—PTGS2—prostate cancer	1.47e-05	0.0052	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.46e-05	0.000432	CbGpPWpGaD
Mometasone—Nausea—Doxorubicin—prostate cancer	1.46e-05	0.000201	CcSEcCtD
Mometasone—NR3C1—Gene Expression—RPL10—prostate cancer	1.46e-05	0.00043	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MBTPS1—prostate cancer	1.43e-05	0.000423	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NAGLU—prostate cancer	1.43e-05	0.000423	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PGAM2—prostate cancer	1.43e-05	0.000423	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SULT2B1—prostate cancer	1.43e-05	0.000423	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM3—prostate cancer	1.43e-05	0.000423	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—RFK—prostate cancer	1.43e-05	0.000423	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AOX1—prostate cancer	1.43e-05	0.000423	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	1.43e-05	0.000423	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.4e-05	0.000413	CbGpPWpGaD
Mometasone—Dexamethasone—CYP2E1—prostate cancer	1.39e-05	0.00491	CrCbGaD
Mometasone—NR3C1—Gene Expression—HIST1H4H—prostate cancer	1.38e-05	0.000408	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NPPA—prostate cancer	1.38e-05	0.000408	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	1.38e-05	0.000407	CbGpPWpGaD
Mometasone—Dexamethasone—CYP2C19—prostate cancer	1.38e-05	0.00486	CrCbGaD
Mometasone—Dexamethasone—CYP1A1—prostate cancer	1.37e-05	0.00484	CrCbGaD
Mometasone—NR3C1—Gene Expression—MED12—prostate cancer	1.36e-05	0.000401	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP3A43—prostate cancer	1.36e-05	0.000401	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AMACR—prostate cancer	1.36e-05	0.000401	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—DEGS1—prostate cancer	1.36e-05	0.000401	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SRD5A2—prostate cancer	1.36e-05	0.000401	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NAT1—prostate cancer	1.36e-05	0.000401	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—prostate cancer	1.34e-05	0.000395	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.33e-05	0.000394	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.33e-05	0.000392	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD17B1—prostate cancer	1.29e-05	0.000382	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.29e-05	0.000382	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	1.25e-05	0.000369	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.24e-05	0.000368	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.24e-05	0.000366	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.23e-05	0.000362	CbGpPWpGaD
Mometasone—Hydrocortisone—CYP3A4—prostate cancer	1.17e-05	0.00415	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.17e-05	0.000345	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	1.16e-05	0.000341	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—RPS19—prostate cancer	1.16e-05	0.000341	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—B4GALT4—prostate cancer	1.15e-05	0.000341	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HPGD—prostate cancer	1.15e-05	0.000341	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—DNMT1—prostate cancer	1.1e-05	0.000326	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	1.1e-05	0.000323	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TNFRSF21—prostate cancer	1.08e-05	0.00032	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NCOA2—prostate cancer	1.08e-05	0.00032	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EZH2—prostate cancer	1.07e-05	0.000316	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTAP—prostate cancer	1.06e-05	0.000312	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP7B1—prostate cancer	1.06e-05	0.000312	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PARP1—prostate cancer	1.05e-05	0.000309	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.03e-05	0.000305	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SULT1E1—prostate cancer	1.03e-05	0.000304	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SRD5A1—prostate cancer	1.03e-05	0.000304	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	1.03e-05	0.000303	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	9.99e-06	0.000295	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HSPA1A—prostate cancer	9.92e-06	0.000293	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR2—prostate cancer	9.92e-06	0.000293	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	9.84e-06	0.000291	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ACSL4—prostate cancer	9.81e-06	0.00029	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD17B3—prostate cancer	9.81e-06	0.00029	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	9.7e-06	0.000286	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UMPS—prostate cancer	9.41e-06	0.000278	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PHGDH—prostate cancer	9.41e-06	0.000278	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ARG2—prostate cancer	9.41e-06	0.000278	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	9.36e-06	0.000276	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LDHB—prostate cancer	9.22e-06	0.000272	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NCOA1—prostate cancer	9.14e-06	0.00027	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP3A5—prostate cancer	9.05e-06	0.000267	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AR—prostate cancer	8.76e-06	0.000259	CbGpPWpGaD
Mometasone—Dexamethasone—CYP3A4—prostate cancer	8.75e-06	0.00309	CrCbGaD
Mometasone—CYP2C8—Metabolism—PDHA1—prostate cancer	8.74e-06	0.000258	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TCN2—prostate cancer	8.74e-06	0.000258	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA3—prostate cancer	8.74e-06	0.000258	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UCP3—prostate cancer	8.74e-06	0.000258	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—RXRA—prostate cancer	8.69e-06	0.000257	CbGpPWpGaD
Mometasone—Dexamethasone—PTGS2—prostate cancer	8.57e-06	0.00302	CrCbGaD
Mometasone—CYP2C8—Metabolism—HSD3B1—prostate cancer	8.34e-06	0.000246	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC22A3—prostate cancer	8.34e-06	0.000246	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.09e-06	0.000239	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TBXAS1—prostate cancer	8e-06	0.000236	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA4—prostate cancer	8e-06	0.000236	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SIRT1—prostate cancer	7.99e-06	0.000236	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—VDR—prostate cancer	7.87e-06	0.000232	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.82e-06	0.000231	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA2—prostate cancer	7.79e-06	0.00023	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCG5—prostate cancer	7.7e-06	0.000227	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SULT1A1—prostate cancer	7.7e-06	0.000227	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA1—prostate cancer	7.52e-06	0.000222	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NAT2—prostate cancer	7.43e-06	0.00022	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTO1—prostate cancer	7.43e-06	0.00022	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD3B2—prostate cancer	7.43e-06	0.00022	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ERCC2—prostate cancer	7.2e-06	0.000213	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.15e-06	0.000211	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLCB2—prostate cancer	7.13e-06	0.00021	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LRP2—prostate cancer	7.13e-06	0.00021	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2C18—prostate cancer	7.13e-06	0.00021	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—P4HB—prostate cancer	6.99e-06	0.000206	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC22A1—prostate cancer	6.8e-06	0.000201	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.72e-06	0.000198	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARA—prostate cancer	6.64e-06	0.000196	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SULT2A1—prostate cancer	6.63e-06	0.000196	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MED12—prostate cancer	6.52e-06	0.000193	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	6.5e-06	0.000192	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GNG5—prostate cancer	6.47e-06	0.000191	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NCOA3—prostate cancer	6.23e-06	0.000184	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.12e-06	0.000181	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR1—prostate cancer	6.02e-06	0.000178	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HPGDS—prostate cancer	5.94e-06	0.000176	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2C19—prostate cancer	5.91e-06	0.000174	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTT1—prostate cancer	5.76e-06	0.00017	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ACHE—prostate cancer	5.76e-06	0.00017	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2A6—prostate cancer	5.7e-06	0.000168	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.68e-06	0.000168	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKR1C3—prostate cancer	5.54e-06	0.000164	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PRKACB—prostate cancer	5.51e-06	0.000163	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP17A1—prostate cancer	5.46e-06	0.000161	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.38e-06	0.000159	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CREBBP—prostate cancer	5.27e-06	0.000156	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NCOA2—prostate cancer	5.2e-06	0.000154	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC5A5—prostate cancer	4.96e-06	0.000146	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SERPINE1—prostate cancer	4.94e-06	0.000146	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2E1—prostate cancer	4.85e-06	0.000143	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NQO1—prostate cancer	4.79e-06	0.000141	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TH—prostate cancer	4.72e-06	0.000139	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.69e-06	0.000139	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP3A4—prostate cancer	4.67e-06	0.000138	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.65e-06	0.000137	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1B1—prostate cancer	4.59e-06	0.000136	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GGT1—prostate cancer	4.45e-06	0.000131	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NCOA1—prostate cancer	4.38e-06	0.000129	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP19A1—prostate cancer	4.32e-06	0.000128	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—RXRA—prostate cancer	4.17e-06	0.000123	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.05e-06	0.00012	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—COMT—prostate cancer	4.01e-06	0.000119	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTP1—prostate cancer	4e-06	0.000118	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ITPR1—prostate cancer	3.93e-06	0.000116	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.87e-06	0.000114	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TYMS—prostate cancer	3.71e-06	0.00011	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM1—prostate cancer	3.67e-06	0.000108	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LPL—prostate cancer	3.6e-06	0.000106	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1A1—prostate cancer	3.48e-06	0.000103	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ERCC2—prostate cancer	3.45e-06	0.000102	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTHFR—prostate cancer	3.25e-06	9.58e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARA—prostate cancer	3.18e-06	9.4e-05	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MYC—prostate cancer	3.13e-06	9.24e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CAV1—prostate cancer	2.99e-06	8.84e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.86e-06	8.44e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.73e-06	8.05e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—INS—prostate cancer	2.58e-06	7.62e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CREBBP—prostate cancer	2.53e-06	7.46e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CD—prostate cancer	2.4e-06	7.08e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NOS3—prostate cancer	2.26e-06	6.68e-05	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—prostate cancer	2.17e-06	6.41e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.09e-06	6.17e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS2—prostate cancer	2.07e-06	6.11e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTEN—prostate cancer	1.81e-06	5.33e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—EP300—prostate cancer	1.72e-06	5.08e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.27e-06	3.76e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—prostate cancer	1.04e-06	3.07e-05	CbGpPWpGaD
